GlaxoSmithKline PLC (NYSE:GSK)

39.74
BATS BZX Real-Time Price
As of 10:24am ET
 -0.24 / -0.60%
Today’s Change
36.41
Today|||52-Week Range
42.36
+4.00%
Year-to-Date
Emergent's (EBS) Chikungunya Vaccine Positive in Phase II Study
Apr 17 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group
Apr 12 / Zacks.com - Paid Partner Content
Axsome's AXS-05 Meets Goal in Phase II Study, Shares Up
Apr 16 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal
Apr 12 / Zacks.com - Paid Partner Content
Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA
Apr 16 / Zacks.com - Paid Partner Content
Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon
Apr 11 / Zacks.com - Paid Partner Content
Would You Loan Me $20? Character in Management
Apr 15 / GuruFocus News - Paid Partner Content
AstraZeneca/Merck's Lynparza Wins EU Nod for Breast Cancer
Apr 10 / Zacks.com - Paid Partner Content
Clovis Stalls Mid-Stage Rubraca Study for Bladder Cancer
Apr 15 / Zacks.com - Paid Partner Content
Emergent's (EBS) Strong Vaccine Portfolio to Fuel Growth
Apr 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close39.98
Today’s open39.95
Day’s range39.74 - 40.00
Volume389,852
Average volume (3 months)3,122,563
Market cap$101.2B
Data as of 10:24am ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)-7.30%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+5.72%
P/E ratio21.0
Price/Sales2.31
Price/Book17.99

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.34-0.86%
SNYSanofi-0.01-0.02%
NVONovo Nordisk-0.67-1.38%
ABBVAbbVie-0.92-1.18%
Data as of 10:25am ET, 04/18/2019

Financials

Next reporting dateMay 1, 2019
EPS forecast (this quarter)$0.66
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Iain James Mackay
Corporate headquarters
Brentford, Greater London

Forecasts